IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS-COV-2 infection: Rationale and protocol of the IMPACT-SIRIO 5 study.

ABSTRACT:

SUBMITTER: Kubica J 

PROVIDER: S-EPMC8890419 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature